The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients

被引:70
作者
Magill, Shelley S. [1 ]
Swoboda, Sandra M.
Johnson, Elizabeth A.
Merz, William G.
Pelz, Robert K.
Lipsett, Pamela A.
Hendrix, Craig W.
机构
[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA
关键词
Candida; candidiasis; fluconazole;
D O I
10.1016/j.diagmicrobio.2006.03.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We evaluated whether the likelihood of developing invasive candidiasis (IC) differed depending upon the anatomic site of Candida colonization in 182 surgical intensive care unit (SICU) patients who participated in a randomized trial of fluconazole to prevent candidiasis. We also determined the impact of Candida colonization of different anatomic sites on all-cause SICU and hospital mortality. A total of 2851 surveillance fungal cultures collected from 5 anatomic sites were analyzed. There was a statistically significant difference in the frequency of IC comparing patients with and without urinary (13.2% versus 2.8%, P =.02), respiratory (8.0% versus 1.2%, P =.04), and rectum/ostomy (8.4% versus 0%, P = .01) colonization. Patients with negative rectum/ostomy cultures and patients with both negative urine and respiratory tract cultures did not develop IC. Candiduria detected at any time in the SICU was independently associated with SICU mortality (odds ratio, 2.86; 95% confidence interval, 1.05-7.74). Surveillance fungal cultures of particular anatomic sites may help differentiate patients at higher risk of developing IC from those at low risk. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 30 条
[1]   Candiduria in critically ill patients admitted to intensive care medical units [J].
Alvarez-Lerma, F ;
Nolla-Salas, J ;
León, C ;
Palomar, M ;
Jordá, R ;
Carrasco, N ;
Bobillo, F .
INTENSIVE CARE MEDICINE, 2003, 29 (07) :1069-1076
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study [J].
Blumberg, HM ;
Jarvis, WR ;
Soucie, JM ;
Edwards, JE ;
Patterson, JE ;
Pfaller, MA ;
Rangel-Frausto, MS ;
Rinaldi, MG ;
Saiman, L ;
Wiblin, RT ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :177-186
[4]   Candida infections in critically ill trauma patients - A retrospective case-control study [J].
Borzotta, AP ;
Beardsley, K .
ARCHIVES OF SURGERY, 1999, 134 (06) :657-664
[5]  
BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4
[6]  
CORNWELL EE, 1995, AM SURGEON, V61, P847
[7]   Value of surveillance cultures in transplantation unit [J].
Czirok, E ;
Prinz, GY ;
Denes, R ;
Remeny, P ;
Herendi, A .
JOURNAL OF MEDICAL MICROBIOLOGY, 1997, 46 (09) :785-791
[8]   Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients [J].
Eggimann, P ;
Francioli, P ;
Bille, J ;
Schneider, R ;
Wu, MM ;
Chapuis, G ;
Chiolero, R ;
Pannatier, A ;
Schilling, J ;
Geroulanos, S ;
Glauser, MP ;
Calandra, T .
CRITICAL CARE MEDICINE, 1999, 27 (06) :1066-1072
[9]   Management of candida species infections in critically ill patients [J].
Eggimann, P ;
Garbino, J ;
Pittet, D .
LANCET INFECTIOUS DISEASES, 2003, 3 (12) :772-785
[10]   Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients:: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination [J].
Garbino, J ;
Lew, DP ;
Romand, JA ;
Hugonnet, S ;
Auckenthaler, R ;
Pittet, D .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1708-1717